Tenacissoside G
CAS: 191729-43-8
Ref. 3D-FT74348
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
- (3beta,5alpha,11alpha,12beta,14beta,17alpha)-12-(Acetyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-beta-D-allopyranosyl)-3-O-methyl-beta-D-arabino-hexopyranosyl]oxy]-8,14-epoxy-11-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]pregnan-20-one
- Tenacissimoside A
- 2-Butenoic acid, 2-methyl-, (3β,5α,11α,12β,14β,17α)-12-(acetyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy]-8,14- epoxy-20-oxopregnan-11-yl ester, (2E)-
- (3β,5α,11α,12β,14β,17α)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl (2E)-2 -methyl-2-butenoate
Tenacissoside G is a saponin that has been extracted from the Chinese herbs, Tenacissus trifoliata and Acanthopanax senticosus. It has been found to have antitumor activity by inhibiting the growth of cancer cells. Tenacissoside G has also been shown to inhibit the production of epidermal growth factor (EGF) and its receptor in human keratinocytes. The pharmacokinetic study showed that Tenacissoside G was absorbed quickly after oral administration, with a peak concentration observed at 1-2 hours after administration. The analytical method for Tenacissoside G is HPLC with UV detection at 254 nm and 280 nm.
Chemical properties
Technical inquiry about: 3D-FT74348 Tenacissoside G
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
